Journal article
Performance and Projected Impact of Synovial Fluid Polymerase Chain Reaction Testing for Patients Evaluated for Septic Arthritis
Clinical infectious diseases
08/31/2026
DOI: 10.1093/cid/ciag476
PMID: 42671259
Abstract
Septic arthritis is an infectious disease emergency. Diagnosis is limited by low sensitivity of synovial fluid cell count and Gram stain and delayed culture results. The impact of PCR testing on clinical care of patients suspected of septic arthritis is unknown.
We conducted a prospective, observational study (2021-23) at nine US EDs of adults evaluated for septic arthritis with synovial fluid culture, and later PCR-tested residual fluid. We report PCR concordance, sensitivity and specificity compared to culture, 30-day diagnosis, and antibiotic delay >1 day, and project the impact of point-of-care PCR resulting.
Of 475 participants, 126 (26.5%) were diagnosed with septic arthritis. Eighty-eight (18.5%) had positive PCR and 80 (16.8%) had positive culture identifying, respectively, Staphylococcus aureus (36 [40.9%] vs. 29 [36.3%]), streptococci (32 [36.4%] vs. 22 [27.5%]), and Neisseria gonorrhoeae (12 [13.6%] vs. 4 [5.0%]). PCR-culture concordance was 89.5%. For PCR-targeted organisms, PCR sensitivity and specificity were 89.2% (95%CI 79.4%-94.7%) and 95.3% (95%CI 92.5%-97.1%), respectively. Fifty-seven (45.2%) participants with septic arthritis had concordant-positive PCR/culture results; 11 (19.3%) had delayed treatment (1-6 days). Nineteen (15.1%) participants with septic arthritis had a PCR-positive/culture-negative result, which occurred more frequently with antibiotic pre-treatment and N. gonorrhoeae; all were treated empirically. Among 28 (5.9%) participants with PCR-positive/culture-negative results, 24 (85.7%) were diagnosed with septic arthritis, endocarditis/bacteremia, or osteomyelitis. Three participants with only PCR-detected N. gonorrhoeae did not receive treatment for this infection.
Adjunctive point-of-care PCR testing would be projected to increase timeliness of ED septic arthritis diagnosis and pathogen-specific treatment. Trial registration ClinicalTrials.gov Identifier: NCT05341908.
Details
- Title: Subtitle
- Performance and Projected Impact of Synovial Fluid Polymerase Chain Reaction Testing for Patients Evaluated for Septic Arthritis
- Creators
- Mark T Steele - University of Missouri–Kansas CityAmy M Stubbs - University of Missouri–Kansas CityAnusha Krishnadasan - Olive View-UCLA Medical CenterLaurie Kemble - University of Missouri–Kansas CityRuoyu Li - Olive View-UCLA Medical CenterWilliam R Mower - Olive View-UCLA Medical CenterJoseph Liao - Olive View-UCLA Medical CenterGregory J Moran - Olive View-UCLA Medical CenterDavid A Talan - Olive View-UCLA Medical CenterEMERGEncy ID NET Study Group
- Resource Type
- Journal article
- Publication Details
- Clinical infectious diseases
- DOI
- 10.1093/cid/ciag476
- PMID
- 42671259
- NLM abbreviation
- Clin Infect Dis
- ISSN
- 1058-4838
- eISSN
- 1537-6591
- Publisher
- Oxford University Press
- Grant note
- Centers for Disease Control and Prevention: U01CK000480 BIOFIRE Diagnostics, LLC (Salt Lake City, Utah)
This project was funded by the Centers for Disease Control and Prevention (U01CK000480). The project was additionally funded through an investigator-initiated grant from BIOFIRE Diagnostics, LLC (Salt Lake City, Utah).
- Language
- English
- Electronic publication date
- 08/31/2026
- Academic Unit
- Emergency Medicine
- Record Identifier
- 9985222744502771
Metrics
2 Record Views